Reducing Radiation for Select Patients with HPV-Associated Mouth and Throat Cancer

Human papillomavirus (HPV)–associated oropharyngeal cancer is on the rise, but at Memorial Sloan Kettering Cancer Center, we have updated our standard of care to substantially reduce the radiation dose to elective regions.

Read the full article here

Related Articles

MSK Research Highlights, June 29, 2023

New MSK research discovered ferroptosis regulators that suggest therapeutic opportunities against hormone receptor-positive cancers; examined how tumor-associated macrophages might be turned against cancer; acquired new…